Noile-Immune Biotech News

Noile-Immune Biotech: Change Report

May 24 01:51 ET

Noile-Immune Biotech: Confirmation letter

May 14 04:07 ET

Noile-Immune Biotech: Quarterly Report - 10th Quarter 1st Quarter (2024/01/01 - 2024/03/31)

May 14 04:05 ET

Noile-Immune Biotech: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

May 14 04:00 ET

Neurimune Biotech: Extraordinary Report

Apr 2 00:49 ET

Noile-Immune Biotech: Corporate Governance Report 2024/03/29

Mar 29 06:57 ET

Noile-Immune Biotech: Matters relating to business plans and growth potential

Mar 29 03:30 ET

Neurimune Biotech: Confirmation

Mar 29 01:19 ET

Noile-Immune Biotech: Internal Control Report - Term 9 (2023/01/01 - 2023/12/31)

Mar 29 01:18 ET

Noile-Immune Biotech: Financial Report - Term 9 (2023/01/01 - 2023/12/31)

Mar 29 01:16 ET

Noile-Immune Biotech: Independent Officer Notification Form

Mar 13 04:00 ET

Neurimune Biotech: change report

Mar 6 02:00 ET

Neurimune Biotech: 2024 Annual General Shareholders' Meeting Convocation Notice and Shareholders' Meeting Materials

Mar 5 18:00 ET

Neurimune Biotech: change report

Feb 15 02:00 ET

Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2023/12 [Japanese GAAP] (unconsolidated)

Feb 13 02:55 ET

Noile-Immune Biotech: Notice regarding revisions to full-year earnings forecasts

Jan 24 19:00 ET

Noile-Immune Biotech: [Delayed]Supplemental Comments on the Termination of the License Agreements for NIB102 and NIB103

Dec 17, 2023 23:00 ET

Noile-Immune Biotech: Announcement on the Termination of License Agreement for NIB102 and NIB103

Dec 15, 2023 05:45 ET

Noile-Immune Biotech: Additional comments on the cancellation of the NIB102 and NIB103 license agreements

Dec 15, 2023 05:45 ET

Noile-Immune Biotech: Notice Concerning Cancellation of NIB102 and NIB103 License Agreements

Dec 15, 2023 05:45 ET